Industry Research Reports
Home > Reports > Chemical & Material > Global Dl-3-N-Butylphthalide Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Dl-3-N-Butylphthalide Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-08-05
Pages: 112 Pages
Report ld: 4868358
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Dl-3-N-Butylphthalide market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
DL-3-n-Butylphthalide is the racemic form of (-)-butylphthalide, a phthalide that has been found in A. graveolens, that has diverse biological activities, including antiplatelet, neuroprotective, and antioxidative properties. DL-3-n-Butylphthalide inhibits ADP-, thrombin-, and arachidonic acid-induced aggregation of isolated washed human platelets when used at concentrations of 30, 100, and 300 µM, respectively. It inhibits the phosphorylation of calcium-dependent cytosolic phospholipase A2 (cPLA2) induced by ADP and reduces thromboxane A2 (TXA2) production induced by thrombin or collagen in isolated washed human platelets at concentrations ranging from 30 to 300 µM. DL-3-n-Butylphthalide also inhibits caspase-3 activation, decreases reactive oxygen species (ROS) production and JNK phosphorylation, and prevents cell death induced by serum deprivation in primary mouse cortical neurons when used at a concentration of 10 µM. It reduces infarct volume, as well as caspase-3 activation and JNK phosphorylation in the peri-infarct region, in a mouse model of right middle cerebral artery occlusion (MCAO) with bilateral common carotid artery ligation when administered at a dose of 100 mg/kg one hour following occlusion.
From a downstream perspective, Capsule accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Dl-3-N-Butylphthalide leading manufacturers including Xianju Pharmaceutical, CSPC Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Xianju Pharmaceutical leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Dl-3-N-Butylphthalide market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Xianju Pharmaceutical
- CSPC Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity≥99%
- Purity≥99.5%
Segment by Application
- Capsule
- Injection Solution
CHAPTER OUTLINE
Chapter 1: Defines the Dl-3-N-Butylphthalide study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Dl-3-N-Butylphthalide: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Dl-3-N-Butylphthalide Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity≥99%
1.2.3 Purity≥99.5%
1.3 Market Segmentation by Application
1.3.1 Global Dl-3-N-Butylphthalide Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Capsule
1.3.3 Injection Solution
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dl-3-N-Butylphthalide Revenue Estimates and Forecasts 2020-2031
2.2 Global Dl-3-N-Butylphthalide Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Dl-3-N-Butylphthalide Sales Estimates and Forecasts 2020-2031
2.4 Global Dl-3-N-Butylphthalide Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Dl-3-N-Butylphthalide Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 China
4 Competition by Manufacturers
4.1 Global Dl-3-N-Butylphthalide Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Dl-3-N-Butylphthalide Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity≥99% Market Size by Manufacturers
4.6 Global Dl-3-N-Butylphthalide Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Dl-3-N-Butylphthalide Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Dl-3-N-Butylphthalide Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Dl-3-N-Butylphthalide Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Dl-3-N-Butylphthalide Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Dl-3-N-Butylphthalide Sales and Revenue by Type (2020-2031)
7.4 North America Dl-3-N-Butylphthalide Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Dl-3-N-Butylphthalide Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Dl-3-N-Butylphthalide Sales and Revenue by Type (2020-2031)
8.4 Europe Dl-3-N-Butylphthalide Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Dl-3-N-Butylphthalide Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Dl-3-N-Butylphthalide Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Dl-3-N-Butylphthalide Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Dl-3-N-Butylphthalide Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Dl-3-N-Butylphthalide Sales and Revenue by Type (2020-2031)
10.4 Central and South America Dl-3-N-Butylphthalide Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Dl-3-N-Butylphthalide Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Dl-3-N-Butylphthalide Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Dl-3-N-Butylphthalide Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Dl-3-N-Butylphthalide Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Xianju Pharmaceutical
12.1.1 Xianju Pharmaceutical Corporation Information
12.1.2 Xianju Pharmaceutical Business Overview
12.1.3 Xianju Pharmaceutical Dl-3-N-Butylphthalide Product Models, Descriptions and Specifications
12.1.4 Xianju Pharmaceutical Dl-3-N-Butylphthalide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Xianju Pharmaceutical Dl-3-N-Butylphthalide Sales by Product in 2024
12.1.6 Xianju Pharmaceutical Dl-3-N-Butylphthalide Sales by Application in 2024
12.1.7 Xianju Pharmaceutical Dl-3-N-Butylphthalide Sales by Geographic Area in 2024
12.1.8 Xianju Pharmaceutical Dl-3-N-Butylphthalide SWOT Analysis
12.1.9 Xianju Pharmaceutical Recent Developments
12.2 CSPC Pharmaceutical
12.2.1 CSPC Pharmaceutical Corporation Information
12.2.2 CSPC Pharmaceutical Business Overview
12.2.3 CSPC Pharmaceutical Dl-3-N-Butylphthalide Product Models, Descriptions and Specifications
12.2.4 CSPC Pharmaceutical Dl-3-N-Butylphthalide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 CSPC Pharmaceutical Dl-3-N-Butylphthalide Sales by Product in 2024
12.2.6 CSPC Pharmaceutical Dl-3-N-Butylphthalide Sales by Application in 2024
12.2.7 CSPC Pharmaceutical Dl-3-N-Butylphthalide Sales by Geographic Area in 2024
12.2.8 CSPC Pharmaceutical Dl-3-N-Butylphthalide SWOT Analysis
12.2.9 CSPC Pharmaceutical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Dl-3-N-Butylphthalide Industry Chain
13.2 Dl-3-N-Butylphthalide Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Dl-3-N-Butylphthalide Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Dl-3-N-Butylphthalide Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Dl-3-N-Butylphthalide Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Dl-3-N-Butylphthalide Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Dl-3-N-Butylphthalide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Dl-3-N-Butylphthalide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Dl-3-N-Butylphthalide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Dl-3-N-Butylphthalide Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Dl-3-N-Butylphthalide Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Dl-3-N-Butylphthalide Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
Table 7. Global Dl-3-N-Butylphthalide Sales by Region (2020-2025) & (kg)
Table 8. Global Dl-3-N-Butylphthalide Sales by Region (2026-2031) & (kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Dl-3-N-Butylphthalide Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
Table 11. Global Dl-3-N-Butylphthalide Production by Region (2020-2025) & (kg)
Table 12. Global Dl-3-N-Butylphthalide Production by Region (2026-2031) & (kg)
Table 13. Global Dl-3-N-Butylphthalide Sales by Manufacturers (2020-2025) & (kg)
Table 14. Global Dl-3-N-Butylphthalide Sales Share by Manufacturers (2020-2025)
Table 15. Global Dl-3-N-Butylphthalide Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Dl-3-N-Butylphthalide Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Dl-3-N-Butylphthalide by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dl-3-N-Butylphthalide as of 2024)
Table 19. Global Dl-3-N-Butylphthalide Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Dl-3-N-Butylphthalide Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/g)
Table 21. Key Manufacturers Dl-3-N-Butylphthalide Manufacturing Base and Headquarters
Table 22. Global Dl-3-N-Butylphthalide Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Dl-3-N-Butylphthalide Sales by Type (2020-2025) & (kg)
Table 26. Global Dl-3-N-Butylphthalide Sales by Type (2026-2031) & (kg)
Table 27. Global Dl-3-N-Butylphthalide Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Dl-3-N-Butylphthalide Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Dl-3-N-Butylphthalide ASP by Type (2020-2031) & (US$/g)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Dl-3-N-Butylphthalide Sales by Application (2020-2025) & (kg)
Table 32. Global Dl-3-N-Butylphthalide Sales by Application (2026-2031) & (kg)
Table 33. Dl-3-N-Butylphthalide High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Dl-3-N-Butylphthalide Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Dl-3-N-Butylphthalide Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Dl-3-N-Butylphthalide ASP by Application (2020-2031) & (US$/g)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Dl-3-N-Butylphthalide Growth Accelerators and Market Barriers
Table 40. North America Dl-3-N-Butylphthalide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Dl-3-N-Butylphthalide Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Dl-3-N-Butylphthalide Growth Accelerators and Market Barriers
Table 43. Europe Dl-3-N-Butylphthalide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Dl-3-N-Butylphthalide Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Dl-3-N-Butylphthalide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Dl-3-N-Butylphthalide Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Dl-3-N-Butylphthalide Growth Accelerators and Market Barriers
Table 48. Southeast Asia Dl-3-N-Butylphthalide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Dl-3-N-Butylphthalide Investment Opportunities and Key Challenges
Table 50. Central and South America Dl-3-N-Butylphthalide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Dl-3-N-Butylphthalide Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Dl-3-N-Butylphthalide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Xianju Pharmaceutical Corporation Information
Table 54. Xianju Pharmaceutical Description and Major Businesses
Table 55. Xianju Pharmaceutical Product Models, Descriptions and Specifications
Table 56. Xianju Pharmaceutical Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 57. Xianju Pharmaceutical Sales Value Proportion by Product in 2024
Table 58. Xianju Pharmaceutical Sales Value Proportion by Application in 2024
Table 59. Xianju Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 60. Xianju Pharmaceutical Dl-3-N-Butylphthalide SWOT Analysis
Table 61. Xianju Pharmaceutical Recent Developments
Table 62. CSPC Pharmaceutical Corporation Information
Table 63. CSPC Pharmaceutical Description and Major Businesses
Table 64. CSPC Pharmaceutical Product Models, Descriptions and Specifications
Table 65. CSPC Pharmaceutical Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 66. CSPC Pharmaceutical Sales Value Proportion by Product in 2024
Table 67. CSPC Pharmaceutical Sales Value Proportion by Application in 2024
Table 68. CSPC Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 69. CSPC Pharmaceutical Dl-3-N-Butylphthalide SWOT Analysis
Table 70. CSPC Pharmaceutical Recent Developments
Table 71. Key Raw Materials Distribution
Table 72. Raw Materials Key Suppliers
Table 73. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 74. Milestones in Production Technology Evolution
Table 75. Distributors List
Table 76. Market Trends and Market Evolution
Table 77. Market Drivers and Opportunities
Table 78. Market Challenges, Risks, and Restraints
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
List of Figures
Figure 1. Dl-3-N-Butylphthalide Product Picture
Figure 2. Global Dl-3-N-Butylphthalide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Purity≥99% Product Picture
Figure 4. Purity≥99.5% Product Picture
Figure 5. Global Dl-3-N-Butylphthalide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Capsule
Figure 7. Injection Solution
Figure 8. Dl-3-N-Butylphthalide Report Years Considered
Figure 9. Global Dl-3-N-Butylphthalide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 11. Global Dl-3-N-Butylphthalide Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Dl-3-N-Butylphthalide Revenue Market Share by Region (2020-2031)
Figure 13. Global Dl-3-N-Butylphthalide Sales (2020-2031) & (kg)
Figure 14. Global Dl-3-N-Butylphthalide Sales (CAGR) by Region (2020-2031) (kg)
Figure 15. Global Dl-3-N-Butylphthalide Sales Market Share by Region (2020-2031)
Figure 16. Global Dl-3-N-Butylphthalide Capacity, Production and Utilization (2020-2031) & (kg)
Figure 17. Global Dl-3-N-Butylphthalide Production Trend by Region (2020-2031) (kg)
Figure 18. Global Dl-3-N-Butylphthalide Production Market Share by Region (2020-2031)
Figure 19. Production Capacity Enablers & Constraints
Figure 20. Dl-3-N-Butylphthalide Production Growth Rate in China (2020-2031) & (kg)
Figure 21. Top 5 and Top 10 Manufacturers Dl-3-N-Butylphthalide Sales Volume Market Share in 2024
Figure 22. Global Dl-3-N-Butylphthalide Revenue Market Share Ranking (2024)
Figure 23. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 24. Purity≥99% Revenue Market Share by Manufacturer in 2024
Figure 25. Purity≥99.5% Revenue Market Share by Manufacturer in 2024
Figure 26. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 27. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 28. Global Dl-3-N-Butylphthalide Sales Market Share by Type (2020-2031)
Figure 29. Global Dl-3-N-Butylphthalide Revenue Market Share by Type (2020-2031)
Figure 30. Global Dl-3-N-Butylphthalide Sales Market Share by Application (2020-2031)
Figure 31. Global Dl-3-N-Butylphthalide Revenue Market Share by Application (2020-2031)
Figure 32. North America Dl-3-N-Butylphthalide Sales YoY (2020-2031) & (kg)
Figure 33. North America Dl-3-N-Butylphthalide Revenue YoY (2020-2031) & (US$ Million)
Figure 34. North America Top 5 Manufacturers Dl-3-N-Butylphthalide Sales Revenue (US$ Million) in 2024
Figure 35. North America Dl-3-N-Butylphthalide Sales Volume (kg) by Type (2020- 2031)
Figure 36. North America Dl-3-N-Butylphthalide Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 37. North America Dl-3-N-Butylphthalide Sales Volume (kg) by Application (2020-2031)
Figure 38. North America Dl-3-N-Butylphthalide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 39. US Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 40. Canada Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 41. Mexico Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 42. Europe Dl-3-N-Butylphthalide Sales YoY (2020-2031) & (kg)
Figure 43. Europe Dl-3-N-Butylphthalide Revenue YoY (2020-2031) & (US$ Million)
Figure 44. Europe Top 5 Manufacturers Dl-3-N-Butylphthalide Sales Revenue (US$ Million) in 2024
Figure 45. Europe Dl-3-N-Butylphthalide Sales Volume (kg) by Type (2020-2031)
Figure 46. Europe Dl-3-N-Butylphthalide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 47. Europe Dl-3-N-Butylphthalide Sales Volume (kg) by Application (2020-2031)
Figure 48. Europe Dl-3-N-Butylphthalide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 49. Germany Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 50. France Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 51. U.K. Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 52. Italy Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 53. Russia Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Dl-3-N-Butylphthalide Sales YoY (2020-2031) & (kg)
Figure 55. Asia-Pacific Dl-3-N-Butylphthalide Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Asia-Pacific Top 8 Manufacturers Dl-3-N-Butylphthalide Sales Revenue (US$ Million) in 2024
Figure 57. Asia-Pacific Dl-3-N-Butylphthalide Sales Volume (kg) by Type (2020- 2031)
Figure 58. Asia-Pacific Dl-3-N-Butylphthalide Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 59. Asia-Pacific Dl-3-N-Butylphthalide Sales Volume (kg) by Application (2020-2031)
Figure 60. Asia-Pacific Dl-3-N-Butylphthalide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 61. Indonesia Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 62. Japan Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 63. South Korea Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 64. China Taiwan Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 65. India Dl-3-N-Butylphthalide Revenue (2020-2031) & (US$ Million)
Figure 66. Central and South America Dl-3-N-Butylphthalide Sales YoY (2020-2031) & (kg)
Figure 67. Central and South America Dl-3-N-Butylphthalide Revenue YoY (2020-2031) & (US$ Million)
Figure 68. Central and South America Top 5 Manufacturers Dl-3-N-Butylphthalide Sales Revenue (US$ Million) in 2024
Figure 69. Central and South America Dl-3-N-Butylphthalide Sales Volume (kg) by Type (2021-2031)
Figure 70. Central and South America Dl-3-N-Butylphthalide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 71. Central and South America Dl-3-N-Butylphthalide Sales Volume (kg) by Application (2020-2031)
Figure 72. Central and South America Dl-3-N-Butylphthalide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 73. Brazil Dl-3-N-Butylphthalide Revenue (2020-2025) & (US$ Million)
Figure 74. Argentina Dl-3-N-Butylphthalide Revenue (2020-2025) & (US$ Million)
Figure 75. Middle East, and Africa Dl-3-N-Butylphthalide Sales YoY (2020-2031) & (kg)
Figure 76. Middle East and Africa Dl-3-N-Butylphthalide Revenue YoY (2020-2031) & (US$ Million)
Figure 77. Middle East and Africa Top 5 Manufacturers Dl-3-N-Butylphthalide Sales Revenue (US$ Million) in 2024
Figure 78. Middle East and Africa Dl-3-N-Butylphthalide Sales Volume (kg) by Type (2021-2031)
Figure 79. South America Dl-3-N-Butylphthalide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 80. Middle East and Africa Dl-3-N-Butylphthalide Sales Volume (kg) by Application (2020-2031)
Figure 81. Middle East and Africa Dl-3-N-Butylphthalide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 82. GCC Countries Dl-3-N-Butylphthalide Revenue (2020-2025) & (US$ Million)
Figure 83. Turkey Dl-3-N-Butylphthalide Revenue (2020-2025) & (US$ Million)
Figure 84. Egypt Dl-3-N-Butylphthalide Revenue (2020-2025) & (US$ Million)
Figure 85. South Africa Dl-3-N-Butylphthalide Revenue (2020-2025) & (US$ Million)
Figure 86. Dl-3-N-Butylphthalide Industry Chain Mapping
Figure 87. Regional Dl-3-N-Butylphthalide Manufacturing Base Distribution (%)
Figure 88. Dl-3-N-Butylphthalide Production Process
Figure 89. Regional Dl-3-N-Butylphthalide Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Dl-3-N-Butylphthalide market?
The top companies in the global Dl-3-N-Butylphthalide market are Xianju Pharmaceutical、CSPC Pharmaceutical.
Related Reports
Global Dl-3-N-Butylphthalide Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Dl-3-N-Butylphthalide market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 123
USD 4900.00
(Single User License)
Global Dl-3-N-Butylphthalide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Dl-3-N-Butylphthalide market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 68
USD 4250.00
(Single User License)
Dl-3-N-Butylphthalide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dl-3-N-Butylphthalide was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 89
USD 3950.00
(Single User License)
Global Dl-3-N-Butylphthalide Market Research Report 2026
The global Dl-3-N-Butylphthalide market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 125
USD 2900.00
(Single User License)
Dl-3-N-Butylphthalide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dl-3-N-Butylphthalide was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-13
Pages: 85
USD 3950.00
(Single User License)
Global Dl-3-N-Butylphthalide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dl-3-N-Butylphthalide market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 75
USD 4250.00
(Single User License)
Global Dl-3-N-Butylphthalide Market Research Report 2025
The global market for Dl-3-N-Butylphthalide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 78
USD 2900.00
(Single User License)
Global Dl-3-N-Butylphthalide Market Research Report 2024
DL-3-n-Butylphthalide is the racemic form of (-)-butylphthalide, a phthalide that has been found in A. graveolens, that has diverse biological activities, including antiplatelet, neuroprotective, and antioxidative properties. DL-3-n-Butylphthalide inhibits ADP-, thrombin-, and arachidonic acid-induced aggregation of isolated washed human platelets when used at concentrations of 30, 100, and 300 µM, respectively. It inhibits the phosphorylation of calcium-dependent cytosolic phospholipase A2 (cPLA2) induced by ADP and reduces thromboxane A2 (TXA2) production induced by thrombin or collagen in isolated washed human platelets at concentrations ranging from 30 to 300 µM. DL-3-n-Butylphthalide also inhibits caspase-3 activation, decreases reactive oxygen species (ROS) production and JNK phosphorylation, and prevents cell death induced by serum deprivation in primary mouse cortical neurons when used at a concentration of 10 µM. It reduces infarct volume, as well as caspase-3 activation and JNK phosphorylation in the peri-infarct region, in a mouse model of right middle cerebral artery occlusion (MCAO) with bilateral common carotid artery ligation when administered at a dose of 100 mg/kg one hour following occlusion.
Published Date: 2024-08-29
Pages: 76
USD 2900.00
(Single User License)
Global and United States Dl-3-N-Butylphthalide Market Report & Forecast 2024-2030
DL-3-n-Butylphthalide is the racemic form of (-)-butylphthalide, a phthalide that has been found in A. graveolens, that has diverse biological activities, including antiplatelet, neuroprotective, and antioxidative properties. DL-3-n-Butylphthalide inhibits ADP-, thrombin-, and arachidonic acid-induced aggregation of isolated washed human platelets when used at concentrations of 30, 100, and 300 µM, respectively. It inhibits the phosphorylation of calcium-dependent cytosolic phospholipase A2 (cPLA2) induced by ADP and reduces thromboxane A2 (TXA2) production induced by thrombin or collagen in isolated washed human platelets at concentrations ranging from 30 to 300 µM. DL-3-n-Butylphthalide also inhibits caspase-3 activation, decreases reactive oxygen species (ROS) production and JNK phosphorylation, and prevents cell death induced by serum deprivation in primary mouse cortical neurons when used at a concentration of 10 µM. It reduces infarct volume, as well as caspase-3 activation and JNK phosphorylation in the peri-infarct region, in a mouse model of right middle cerebral artery occlusion (MCAO) with bilateral common carotid artery ligation when administered at a dose of 100 mg/kg one hour following occlusion.
Published Date: 2024-08-29
Pages: 94
USD 4350.00
(Single User License)
Global Dl-3-N-Butylphthalide Market Insights, Forecast to 2030
DL-3-n-Butylphthalide is the racemic form of (-)-butylphthalide, a phthalide that has been found in A. graveolens, that has diverse biological activities, including antiplatelet, neuroprotective, and antioxidative properties. DL-3-n-Butylphthalide inhibits ADP-, thrombin-, and arachidonic acid-induced aggregation of isolated washed human platelets when used at concentrations of 30, 100, and 300 µM, respectively. It inhibits the phosphorylation of calcium-dependent cytosolic phospholipase A2 (cPLA2) induced by ADP and reduces thromboxane A2 (TXA2) production induced by thrombin or collagen in isolated washed human platelets at concentrations ranging from 30 to 300 µM. DL-3-n-Butylphthalide also inhibits caspase-3 activation, decreases reactive oxygen species (ROS) production and JNK phosphorylation, and prevents cell death induced by serum deprivation in primary mouse cortical neurons when used at a concentration of 10 µM. It reduces infarct volume, as well as caspase-3 activation and JNK phosphorylation in the peri-infarct region, in a mouse model of right middle cerebral artery occlusion (MCAO) with bilateral common carotid artery ligation when administered at a dose of 100 mg/kg one hour following occlusion.
Published Date: 2024-08-29
Pages: 125
USD 4900.00
(Single User License)
Global Dl-3-N-Butylphthalide Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Dl-3-N-Butylphthalide market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 123
USD 4900.00 (Single User License)Global Dl-3-N-Butylphthalide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Dl-3-N-Butylphthalide market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 68
USD 4250.00 (Single User License)Dl-3-N-Butylphthalide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dl-3-N-Butylphthalide was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 89
USD 3950.00 (Single User License)Global Dl-3-N-Butylphthalide Market Research Report 2026
The global Dl-3-N-Butylphthalide market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 125
USD 2900.00 (Single User License)Dl-3-N-Butylphthalide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dl-3-N-Butylphthalide was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-13
Pages: 85
USD 3950.00 (Single User License)Global Dl-3-N-Butylphthalide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dl-3-N-Butylphthalide market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 75
USD 4250.00 (Single User License)Global Dl-3-N-Butylphthalide Market Research Report 2025
The global market for Dl-3-N-Butylphthalide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 78
USD 2900.00 (Single User License)Global Dl-3-N-Butylphthalide Market Research Report 2024
DL-3-n-Butylphthalide is the racemic form of (-)-butylphthalide, a phthalide that has been found in A. graveolens, that has diverse biological activities, including antiplatelet, neuroprotective, and antioxidative properties. DL-3-n-Butylphthalide inhibits ADP-, thrombin-, and arachidonic acid-induced aggregation of isolated washed human platelets when used at concentrations of 30, 100, and 300 µM, respectively. It inhibits the phosphorylation of calcium-dependent cytosolic phospholipase A2 (cPLA2) induced by ADP and reduces thromboxane A2 (TXA2) production induced by thrombin or collagen in isolated washed human platelets at concentrations ranging from 30 to 300 µM. DL-3-n-Butylphthalide also inhibits caspase-3 activation, decreases reactive oxygen species (ROS) production and JNK phosphorylation, and prevents cell death induced by serum deprivation in primary mouse cortical neurons when used at a concentration of 10 µM. It reduces infarct volume, as well as caspase-3 activation and JNK phosphorylation in the peri-infarct region, in a mouse model of right middle cerebral artery occlusion (MCAO) with bilateral common carotid artery ligation when administered at a dose of 100 mg/kg one hour following occlusion.
Published: 2024-08-29
Pages: 76
USD 2900.00 (Single User License)Global and United States Dl-3-N-Butylphthalide Market Report & Forecast 2024-2030
DL-3-n-Butylphthalide is the racemic form of (-)-butylphthalide, a phthalide that has been found in A. graveolens, that has diverse biological activities, including antiplatelet, neuroprotective, and antioxidative properties. DL-3-n-Butylphthalide inhibits ADP-, thrombin-, and arachidonic acid-induced aggregation of isolated washed human platelets when used at concentrations of 30, 100, and 300 µM, respectively. It inhibits the phosphorylation of calcium-dependent cytosolic phospholipase A2 (cPLA2) induced by ADP and reduces thromboxane A2 (TXA2) production induced by thrombin or collagen in isolated washed human platelets at concentrations ranging from 30 to 300 µM. DL-3-n-Butylphthalide also inhibits caspase-3 activation, decreases reactive oxygen species (ROS) production and JNK phosphorylation, and prevents cell death induced by serum deprivation in primary mouse cortical neurons when used at a concentration of 10 µM. It reduces infarct volume, as well as caspase-3 activation and JNK phosphorylation in the peri-infarct region, in a mouse model of right middle cerebral artery occlusion (MCAO) with bilateral common carotid artery ligation when administered at a dose of 100 mg/kg one hour following occlusion.
Published: 2024-08-29
Pages: 94
USD 4350.00 (Single User License)Global Dl-3-N-Butylphthalide Market Insights, Forecast to 2030
DL-3-n-Butylphthalide is the racemic form of (-)-butylphthalide, a phthalide that has been found in A. graveolens, that has diverse biological activities, including antiplatelet, neuroprotective, and antioxidative properties. DL-3-n-Butylphthalide inhibits ADP-, thrombin-, and arachidonic acid-induced aggregation of isolated washed human platelets when used at concentrations of 30, 100, and 300 µM, respectively. It inhibits the phosphorylation of calcium-dependent cytosolic phospholipase A2 (cPLA2) induced by ADP and reduces thromboxane A2 (TXA2) production induced by thrombin or collagen in isolated washed human platelets at concentrations ranging from 30 to 300 µM. DL-3-n-Butylphthalide also inhibits caspase-3 activation, decreases reactive oxygen species (ROS) production and JNK phosphorylation, and prevents cell death induced by serum deprivation in primary mouse cortical neurons when used at a concentration of 10 µM. It reduces infarct volume, as well as caspase-3 activation and JNK phosphorylation in the peri-infarct region, in a mouse model of right middle cerebral artery occlusion (MCAO) with bilateral common carotid artery ligation when administered at a dose of 100 mg/kg one hour following occlusion.
Published: 2024-08-29
Pages: 125
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now